FY2027 EPS Estimates for HCA Healthcare Lifted by Analyst

HCA Healthcare, Inc. (NYSE:HCAFree Report) – Equities research analysts at Leerink Partnrs upped their FY2027 earnings per share (EPS) estimates for shares of HCA Healthcare in a report issued on Monday, January 27th. Leerink Partnrs analyst W. Mayo now forecasts that the company will earn $32.55 per share for the year, up from their prior forecast of $30.68. The consensus estimate for HCA Healthcare’s current full-year earnings is $21.75 per share.

A number of other brokerages have also issued reports on HCA. TD Cowen dropped their price target on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a research note on Monday, October 28th. KeyCorp reduced their price target on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 7th. JPMorgan Chase & Co. restated a “neutral” rating and set a $380.00 price objective on shares of HCA Healthcare in a research note on Tuesday, December 17th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $405.00 price target on shares of HCA Healthcare in a report on Monday. Finally, StockNews.com lowered shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Monday, November 4th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $382.19.

Check Out Our Latest Report on HCA Healthcare

HCA Healthcare Price Performance

Shares of NYSE HCA opened at $334.66 on Wednesday. The firm has a market cap of $84.77 billion, a PE ratio of 15.03, a price-to-earnings-growth ratio of 1.09 and a beta of 1.64. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. The business has a 50 day moving average price of $313.18 and a two-hundred day moving average price of $353.09. HCA Healthcare has a fifty-two week low of $289.98 and a fifty-two week high of $417.14.

HCA Healthcare (NYSE:HCAGet Free Report) last released its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, beating analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.52% and a return on equity of 520.98%. During the same quarter last year, the business posted $5.90 earnings per share.

Institutional Trading of HCA Healthcare

Hedge funds have recently bought and sold shares of the company. MML Investors Services LLC lifted its position in shares of HCA Healthcare by 31.7% in the 3rd quarter. MML Investors Services LLC now owns 17,816 shares of the company’s stock valued at $7,241,000 after acquiring an additional 4,285 shares in the last quarter. Meritage Group LP acquired a new stake in shares of HCA Healthcare in the third quarter worth $150,548,000. Galvin Gaustad & Stein LLC purchased a new stake in HCA Healthcare in the 4th quarter worth about $18,044,000. Alpha DNA Investment Management LLC purchased a new position in HCA Healthcare during the 3rd quarter valued at about $869,000. Finally, NRI Wealth Management LC acquired a new stake in shares of HCA Healthcare during the fourth quarter worth approximately $2,896,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, SVP Phillip G. Billington sold 3,897 shares of the firm’s stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the completion of the transaction, the senior vice president now owns 52,702 shares in the company, valued at approximately $18,445,700. This trade represents a 6.89 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider Erol R. Akdamar sold 2,900 shares of the stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the sale, the insider now directly owns 6,843 shares of the company’s stock, valued at approximately $2,415,579. This represents a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is owned by corporate insiders.

HCA Healthcare Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 17th will be issued a $0.72 dividend. The ex-dividend date is Monday, March 17th. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 annualized dividend and a dividend yield of 0.86%. HCA Healthcare’s dividend payout ratio (DPR) is 11.85%.

HCA Healthcare Company Profile

(Get Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

See Also

Earnings History and Estimates for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.